DUBLIN, March 26, 2024 /CNW/ -- Endo International plc (OTC:ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.
Read more at newswire.caEndo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here